The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.
This new seven-country study from the author contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Report Highlights
Market shares of leading suppliers
Business and technological trends in major markets
Five-year test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Strategic profiles of leading market players and start-up firms developing innovative products
Specific product and business opportunities for instrument and consumable suppliers.
Rationale
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Geographic Coverage
France
Germany
Italy
Japan
Spain
UK
USA
Worldwide Market Overview
Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.
Five-year test volume and sales projections by country.
Market Segmentation Analysis
Five-year test volume and sales projections.
A comprehensive analysis of the sequencing market by country and laboratory segment.
Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Product/Technology Review
Comparison of the major molecular diagnostic analyzers.
Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diadexus
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
Specific new product development opportunities with potentially significant market appeal during the next five years.
StatLab Medical Products ("StatLab"), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory ("SDL"), a Chicago-based manufacturer of printed diagnostic...
Global metalworking fluid, grease, and lubricating oil manufacturers, notably those seeking new, more sustainable lubricants using renewable base oils/high-quality additives for the automotive and electric vehicle (EV) industries, can anticipate new...
LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Chief Executive Officer, President and member...
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Jade Cusick as its new Chief Commercial Officer and member of the Ontada leadership...
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to patients suffering from devastating autoimmune diseases and cancers, today announced the...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and...